SEVERE EOSINOPHILIC ASTHMA
Clinical trials for SEVERE EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new SEVERE EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for SEVERE EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World study tests Benralizumab's impact on severe asthma control
Disease control Recruiting nowThis study follows 300 adults with severe eosinophilic asthma who are prescribed benralizumab as part of their normal care in Germany. Researchers will track changes in asthma control, lung function, and medication use over one year. The goal is to see how the drug performs outsi…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New study tests if asthma drug can stop symptoms Long-Term
Disease control Recruiting nowThis study follows 335 adults with severe eosinophilic asthma who are taking benralizumab. Researchers want to see if the drug helps patients achieve partial or complete clinical remission—meaning fewer symptoms, no need for steroid pills, and better lung function—over 12 to 24 m…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for kids with severe asthma: drug aims to cut attacks
Disease control Recruiting nowThis study tests whether benralizumab, an injected drug, can reduce asthma attacks in children aged 6 to 17 with severe eosinophilic asthma. About 200 participants will receive either benralizumab or a placebo, and researchers will track how long it takes for their first asthma f…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug 610 aims to tame severe asthma attacks
Disease control Recruiting nowThis Phase 3 trial tests a new drug called 610 in 480 Chinese adults with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. Participants receive either 610 or a placebo injection for 52 weeks. The main goal is to see if 610 reduces t…
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Real-World study tracks Benralizumab's impact on severe asthma in china
Knowledge-focused Recruiting nowThis study follows 1,000 people aged 12 and older in China who have severe eosinophilic asthma and are prescribed benralizumab. Researchers will track how well the drug controls asthma symptoms over time using questionnaires, and note reasons for stopping or switching treatment. …
Matched conditions: SEVERE EOSINOPHILIC ASTHMA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC